Launch of HIV medication, Lenacapavir to be held on Friday President Cyril Ramaphosa is expected to launch the roll out of the lifesaving HIV prevention injectable medicine, Lenacapavir, later this ...
The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa ...
Daily Maverick on MSN
The evolution of HIV treatment: From multi-pill regimens to better, single-pill combos
HIV treatment has been improved and simplified significantly over the years, yet a small fraction of people living with HIV ...
Health experts say false claims about the lenacapavir injection could undermine efforts to reduce new HIV infections in South ...
Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health ...
PrEP and PEP are important HIV prevention tools that hospitalists should understand and discuss with patients during hospital ...
President Cyril Ramaphosa is set to launch Lenacapavir, a new long-acting HIV prevention injection, in Secunda, Mpumalanga.
The HIV market offers opportunities in unmet needs, R&D advancements, and long-acting treatments in the 7MM, focusing on innovative products and strategic partnerships to capture modest growth from ...
Gilead Sciences is maintained at 'Hold' as the HIV franchise drives growth, but the oncology pipeline requires further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results